Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004285:Dogs; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D051381:Rats
D006834:Hydrazines; D004295:Dihydroxyphenylalanine